OpenURL Connection Search

Select item for more details and to access through your institution.

HER-2-Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents.
Published in:
Annals of the New York Academy of Sciences, 2003, v. 1002, n. 1, p. 78, doi. 10.1196/annals.1281.018
By:
- RAIT, ANTONINA S.;
- PIROLLO, KATHLEEN F.;
- ULICK, DAVID;
- CULLEN, KEVIN;
- CHANG, ESTHER H.
Publication type:
Article
Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer.
Published in:
Cancer Gene Therapy, 2001, v. 8, n. 10, p. 728, doi. 10.1038/sj.cgt.7700359
By:
- Rait, Antonina S;
- Pirollo, Kathleen F;
- Rait, Vladimir;
- Krygier, Jeffrey E;
- Xiang, Laiman;
- Chang, Esther H
Publication type:
Article
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Published in:
2019
By:
- Gunaratne, Preethi H.;
- Pan, Yinghong;
- Rao, Abhi K.;
- Lin, Chunru;
- Hernandez‐Herrera, Anadulce;
- Liang, Ke;
- Rait, Antonina S.;
- Venkatanarayan, Avinashnarayan;
- Benham, Ashley L.;
- Rubab, Farwah;
- Kim, Sang Soo;
- Rajapakshe, Kimal;
- Chan, Clara K.;
- Mangala, Lingegowda S.;
- Lopez‐Berestein, Gabriel;
- Sood, Anil K.;
- Rowat, Amy C.;
- Coarfa, Cristian;
- Pirollo, Kathleen F.;
- Flores, Elsa R.
Publication type:
journal article
A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate.
Published in:
International Journal of Nanomedicine, 2024, v. 19, p. 307, doi. 10.2147/IJN.S443498
By:
- Pirollo, Kathleen F;
- Moghe, Manish;
- Guan, Miaoyin;
- Rait, Antonina S;
- Wang, Aibing;
- Kim, Sang-Soo;
- Chang, Esther H;
- Harford, Joe B
Publication type:
Article

Found: 4

HER-2-Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents.

Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer.

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.

A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate.